Keywords
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Bromocriptine (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Bromocriptine (pharmacology) < Bromocriptine (therapeutic use) < Bromodeoxyuridine  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000013 (1998) Ropinirole: new preparation. Wait for more convincing data.
000064 (1999) J L Montastruc [France] ; O. Rascol ; J M SenardTreatment of Parkinson's disease should begin with a dopamine agonist.
000074 (1999) S. Champagne [France] ; E. Coste ; H. Peyrière ; J. Nigond ; E. Mania ; M. Pons ; D. Hillaire-Buys ; P. Balmes ; J P Blayac ; J M DavyChronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
000191 (2001) J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-CourbonLong-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
000199 (2000) Pergolide and Parkinson's disease: new preparation. No clear benefit.
000282 (????) Jacques Serratrice [France] ; Patrick Disdier ; Gilbert Habib ; François Viallet ; Pierre-Jean WeillerFibrotic valvular heart disease subsequent to bromocriptine treatment.
000422 (1992) G. Durrieu [France] ; M E Llau ; O. Rascol ; J M Senard ; A. Rascol ; J L MontastrucParkinson's disease and weight loss: a study with anthropometric and nutritional assessment.
000517 (2005) Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
000584 (2006) Djamel Ben Smaïl [France] ; Christiane Samuel ; Karine Rouy-Thenaisy ; Joelle Régnault ; Philippe AzouviBromocriptine in traumatic brain injury.
000720 (1991) H. Allain [France] ; F. Le Coz ; F. Goulley ; F. Brunet-Bourgin ; Y. Loria ; D. Bentue-Ferrer ; R. Decombe ; J M Reymann ; P. Chaumet-Riffaud ; J M GandonComparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover study.
001162 (2014) Thomas Cautres [France] ; Michel Cautres [France] ; Dania Mohty [France]Multiple valvular regurgitation associated with bromocriptine therapy.
001890 (1989) J L Montastruc ; O. Rascol ; A. RascolA randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.
001C41 (1988) D. Bentué-Ferrer [France] ; H. Allain ; J M Reymann ; O. Sabouraud ; J. Van Den DriesscheLack of pharmacokinetic influence on levodopa by bromocriptine.
001D06 (1994) O. Rascol [France] ; N. Fabre ; O. Blin ; J. Poulik ; U. Sabatini ; J M Senard ; M. Ané ; J L Montastruc ; A. RascolNaltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.
001D17 (1994) J L Montastruc ; O. Rascol ; J M Senard ; A. RascolA randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
001D50 (1993) L. Rumbach [France] ; C. Tranchant ; J F Viel ; J M WarterEvent-related potentials in Parkinson's disease: a 12-month follow-up study.
001D79 (1995) A M Bonnet [France] ; I. Serre ; R. Marconi ; Yves Agid [France] ; B. DuboisA "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
001E29 (1996) F. Picard [France] ; A. De Saint-Martin ; E. Salmon ; E. Hirsch ; C. MarescauxPostencephalitic stereotyped involuntary movements responsive to L-Dopa.
001E31 (1996) J L Montastruc [France] ; O. Rascol ; J M SenardNew directions in the drug treatment of Parkinson's disease.
001E99 (1997) J. Senard ; S. Rai ; M. Lapeyre-Mestre ; C. Brefel ; O. Rascol ; A. Rascol ; J. MontastrucPrevalence of orthostatic hypotension in Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Bromocriptine (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Bromocriptine (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Bromocriptine (therapeutic use)
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024